Artificial intelligence-based software as a medical device: regulatory evolution toward continuous oversight

Medical Review · Published 2026-07-30 · DOI 10.1515/mr-2026-0027

Free full text

Authors (3)

Yukun Dong, Ping Jiang, Xiao-Hua Zhou

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Dong, Y., Jiang, P., Zhou, X. (2026). Artificial intelligence-based software as a medical device: regulatory evolution toward continuous oversight. Medical Review. https://doi.org/10.1515/mr-2026-0027

Related articles

• Towards a feature-based regulatory benchmark for user-centred SaMD design in cancer care · BMJ Health & Care Informatics · 2026 · Cites or is cited by this article
• Use and Public Reporting of Predetermined Change Control Plans for AI-Enabled Medical Devices · JAMA Health Forum · 2026 · Cites or is cited by this article
• When biomarkers for major depressive disorder remain elusive · Medical Review · 2024 · Same journal
• Gaseous biomarkers speak medical conditions · Medical Review · 2026 · Same journal
• Unfolding ecDNA as a pan-cancer therapeutic target · Medical Review · 2025 · Same journal
• The AI doctor will see you soon: from assistants to autonomous practitioners · Medical Review · 2025 · Same journal
• Target discovery-directed pharmacological mechanism elucidation of bioactive natural products · Medical Review · 2025 · Same journal
• Severe trauma care: advances and future directions in diagnostic and therapeutic techniques and information technology support · Medical Review · 2026 · Same journal
• Proactive personalized early warning systems: the next frontier in climate–health preparedness · Medical Review · 2026 · Same journal
• Transfer RNA-derived small RNAs (tsRNAs) in Alzheimer’s disease: emerging mechanisms and diagnostic potential · Medical Review · 2026 · Same journal